Nicotin Fruitmint Beta (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Nicotin Fruitmint Beta, is a nicotinic receptor agonist presented as an oral formulation for oral use. It helps adults who are trying to quit smoking by reducing nicotine withdrawal symptoms and cravings.

GNH USA supplies Nicotin Fruitmint Beta as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine Resinate is employed in smoking cessation, acting on nicotinic acetylcholine receptors to lessen dependence on tobacco.

Smoking cessation: reduces withdrawal symptoms and cravings, supporting quit attempts. Nicotine dependence: facilitates gradual reduction of nicotine intake in adult smokers. Relapse prevention: helps maintain abstinence after initial cessation by stabilizing nicotinic receptor activity.

Oral Nicotine Resinate may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Mouth irritation or tingling - Headache - Dizziness - Insomnia - Gastrointestinal discomfort

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Cardiovascular events such as hypertension or arrhythmia - Seizures - Respiratory distress - Significant hypotension

When considering Nicotine Resinate, several precautionary measures should be observed to ensure safe use. - Cardiovascular assessment: evaluate patients with known heart disease before initiating therapy. - Hypertension monitoring: avoid use in uncontrolled high blood pressure. - Allergic reaction watch: discontinue if signs of rash, swelling, or breathing difficulty appear. - Psychiatric conditions: use with caution in patients with anxiety or depression, as nicotine can affect mood. - Pediatric use: not recommended for children or adolescents. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine Resinate can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Certain antihypertensive agents (beta‑blockers): nicotine may diminish their blood‑pressure‑lowering effect.

Moderate Interactions (Monitor Closely): - Caffeine: concurrent use may heighten nervousness or insomnia. - Alcohol: combined use can exacerbate cardiovascular strain. - Antipsychotic drugs (e.g., clozapine): nicotine may affect plasma levels, requiring dose adjustment. - Hormone replacement therapy: nicotine may influence metabolism of estrogen compounds.